Analysts See $1.93 EPS for Mesa Laboratories, Inc. (MLAB) on June, 6

May 17, 2018 - By Andrea Bass

Mesa Laboratories, Inc. (NASDAQ:MLAB) Corporate Logo
During Q4 2017 the big money sentiment decreased to 1.21. That’s change of 0.67, from 2017Q3’s 1.88. 12 investors sold all, 26 reduced holdings as Mesa Laboratories, Inc. ratio worsened. 37 rose holdings while 9 funds bought holdings. Funds hold 2.66 million shares thus 6.81% more from 2017Q3’s 2.49 million shares.
Thomson Horstmann And Bryant holds 1.45% or 88,379 shs. California State Teachers Retirement reported 5,118 shs stake. Wasatch Advsrs Inc accumulated 29,132 shs or 0.05% of the stock. Ranger Inv Mngmt Lp owns 13,230 shs or 0.12% of their US capital. Schwab Charles Invest Management owns 0% invested in Mesa Laboratories, Inc. (NASDAQ:MLAB) for 14,223 shs. Arrowmark Colorado Liability Co reported 0.07% of its capital in Mesa Laboratories, Inc. (NASDAQ:MLAB). Legal General Grp Pcl reported 0% stake. Deutsche Financial Bank Ag reported 7,140 shs. Price T Rowe Assocs Incorporated Md invested 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). 4,022 are held by Royal State Bank Of Canada. Us State Bank De has invested 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Parametric Portfolio Assocs Ltd Liability Company owns 3,934 shs. Rice Hall James & Assoc Ltd Liability reported 12,435 shs. Barclays Public Ltd Com has invested 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Moreover, Morgan Stanley has 0% invested in Mesa Laboratories, Inc. (NASDAQ:MLAB).

Mesa Laboratories, Inc. registered $1.27 million net activity with 0 insider buys and 2 sales since February 15, 2018. The insider Dwyer Robert V sold $720,055.

On June, 6. Investors expect Mesa Laboratories, Inc. (NASDAQ:MLAB) to reveal its quarterly earnings, according to RTT. Analysts forecast 55.65 % diference or $1.93 from the $1.24 EPS from 2017. If the current earnings per share of $1.93 is accurate, MLAB’s profit could be $7.30 million. After $-0.24 earnings per share was reported last quarter, analysts now see EPS growth of -904.17 % for Mesa Laboratories, Inc.. MLAB reached $169.8 during the last trading session after $1.67 change.Mesa Laboratories, Inc. has volume of 9,754 shares. Since May 17, 2017 MLAB has risen 13.08% and is uptrending. MLAB outperformed the S&P 500 by 1.53%.

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products.The firm is valued at $642.38 million. The company??s Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.Last it reported negative earnings. This segment??s products are used in healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling, and semiconductor industries.

Mesa Laboratories, Inc. (NASDAQ:MLAB) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: